Cross-border Merger and Acquisitions (M&A) Challenges and Opportunities - China’s largest pharma M&A case studies: Exploring Practice-Led Research for Professional Development. IGI Global

Tan Yang; Jiyao Xun

Cross-border Merger and Acquisitions (M&A) Challenges and Opportunities - China’s largest pharma M&A case studies: Exploring Practice-Led Research for Professional Development. IGI Global

^*Corresponding author for this work

EEH Academic

Research output: Book/Report/Edited volume › Book › peer-review

Original language	English
Place of Publication	Chapter 5
Publisher	IGI Global
Publication status	Accepted/In press - Aug 2024

Cite this

@book{ef794c5e0f8a416eaf575192de098b75,

title = "Cross-border Merger and Acquisitions (M&A) Challenges and Opportunities - China{\textquoteright}s largest pharma M&A case studies: Exploring Practice-Led Research for Professional Development. IGI Global",

author = "Tan Yang and Jiyao Xun",

year = "2024",

month = aug,

language = "English",

publisher = "IGI Global",

}

TY - BOOK

T1 - Cross-border Merger and Acquisitions (M&A) Challenges and Opportunities - China’s largest pharma M&A case studies

T2 - Exploring Practice-Led Research for Professional Development. IGI Global

AU - Yang, Tan

AU - Xun, Jiyao

PY - 2024/8

Y1 - 2024/8

M3 - Book

BT - Cross-border Merger and Acquisitions (M&A) Challenges and Opportunities - China’s largest pharma M&A case studies

PB - IGI Global

CY - Chapter 5

ER -